Improving HIV prevention services for mothers and infants in Kenya
Evaluating the HITSystem to Improve PMTCT Retention and Maternal Viral Suppression in Kenya
['FUNDING_R01'] · UNIVERSITY OF KANSAS MEDICAL CENTER · NIH-10740896
This study is testing a new digital tool called HITSystem 2.1 to help pregnant women in Kenya get better care and support for preventing the spread of HIV to their babies, making it easier for them to stick to their treatment plans during and after pregnancy.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF KANSAS MEDICAL CENTER (nih funded) |
| Locations | 1 site (KANSAS CITY, UNITED STATES) |
| Trial ID | NIH-10740896 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the prevention of mother-to-child transmission (PMTCT) of HIV in Kenya by implementing an innovative eHealth intervention called HITSystem 2.1. The study will take place in 12 government hospitals and aims to improve maternal retention in care and adherence to treatment guidelines. By utilizing a cluster randomized control design, the research will evaluate how effectively the HITSystem 2.1 can increase the uptake of PMTCT services and support maternal viral load suppression during pregnancy and after childbirth.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant women living with HIV in Kenya who are seeking PMTCT services.
Not a fit: Patients who are not pregnant or do not have HIV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the number of infants infected with HIV by improving maternal health care and treatment adherence.
How similar studies have performed: Previous research has shown success with similar eHealth interventions in improving healthcare delivery and patient outcomes in HIV care.
Where this research is happening
KANSAS CITY, UNITED STATES
- UNIVERSITY OF KANSAS MEDICAL CENTER — KANSAS CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KESSLER, SARAH FINOCCHARIO — UNIVERSITY OF KANSAS MEDICAL CENTER
- Study coordinator: KESSLER, SARAH FINOCCHARIO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome